




Searching News Database: otitis media
HSMN NewsFeed - 28 May 2020
Smith & Nephew announces US launch of the revolutionary Tula(R) System for placement of ear tubes
Smith & Nephew announces US launch of the revolutionary Tula(R) System for placement of ear tubes
HSMN NewsFeed - 6 Dec 2017
Third Respiratory Assay Now FDA Cleared on Hologic's New Panther Fusion(R) System
Third Respiratory Assay Now FDA Cleared on Hologic's New Panther Fusion(R) System
HSMN NewsFeed - 20 May 2016
Otonomy Announces Assignment of C Code and Pass-Through Payment Status for OTIPRIO(TM)
Otonomy Announces Assignment of C Code and Pass-Through Payment Status for OTIPRIO(TM)
HSMN NewsFeed - 30 Nov 2015
OticPharma Appoints Keith A. Katkin as Chairman of the Board of Directors
OticPharma Appoints Keith A. Katkin as Chairman of the Board of Directors
HSMN NewsFeed - 22 Feb 2013
Lupin Receives FDA Approval for New Drug Application for SUPRAX(R) Oral Suspension, 500 mg/5mL
Lupin Receives FDA Approval for New Drug Application for SUPRAX(R) Oral Suspension, 500 mg/5mL
HSMN NewsFeed - 15 Apr 2011
FDA Approves ACTEMRA(R) (tocilizumab) for the Treatment of Systemic Juvenile Idiopathic Arthritis (SJIA)
FDA Approves ACTEMRA(R) (tocilizumab) for the Treatment of Systemic Juvenile Idiopathic Arthritis (SJIA)
HSMN NewsFeed - 3 Feb 2011
Otonomy Adds Key Product and Industry Experience with Appointment of New Vice Presidents
Otonomy Adds Key Product and Industry Experience with Appointment of New Vice Presidents
HSMN NewsFeed - 17 Feb 2010
Otonomy Receives FDA Clearance to Initiate Clinical Trial in Patients with Meniere's Disease
Otonomy Receives FDA Clearance to Initiate Clinical Trial in Patients with Meniere's Disease
HSMN NewsFeed - 5 Oct 2009
PEAK Surgical and Medtronic Announce Global Distribution Agreement for the Ear, Nose, and Throat Market
PEAK Surgical and Medtronic Announce Global Distribution Agreement for the Ear, Nose, and Throat Market
HSMN NewsFeed - 13 Jan 2009
Merck Statement in Response to the FDA's Update Regarding a Safety Review of SINGULAIR® (montelukast)
Merck Statement in Response to the FDA's Update Regarding a Safety Review of SINGULAIR® (montelukast)
HSMN NewsFeed - 16 Jul 2008
Sagent Pharmaceuticals Launches Ceftriaxone, USP, and Cefuroxime for Injection, USP
Sagent Pharmaceuticals Launches Ceftriaxone, USP, and Cefuroxime for Injection, USP
HSMN NewsFeed - 6 Feb 2008
Ranbaxy Gains Approval to Manufacture and Market Cefuroxime Axetil for Oral Suspension
Ranbaxy Gains Approval to Manufacture and Market Cefuroxime Axetil for Oral Suspension
HSMN NewsFeed - 24 Jan 2008
FDA Approves MiddleBrook's Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
FDA Approves MiddleBrook's Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
HSMN NewsFeed - 12 Dec 2007
Merck Announces Voluntary Recall of Certain Lots of PEDVAXHIB(R) and COMVAX(R)
Merck Announces Voluntary Recall of Certain Lots of PEDVAXHIB(R) and COMVAX(R)
HSMN NewsFeed - 2 Oct 2007
First-Of-Its-Kind Home-Use Monitor Detects Key Sign Of Middle Ear Infection In Children
First-Of-Its-Kind Home-Use Monitor Detects Key Sign Of Middle Ear Infection In Children
HSMN NewsFeed - 21 Sep 2007
Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome
Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome
HSMN NewsFeed - 26 Jun 2007
Advancis Pharmaceutical Reports on Meeting with FDA Reviewing Keflex PULSYS Phase III Trial Design
Advancis Pharmaceutical Reports on Meeting with FDA Reviewing Keflex PULSYS Phase III Trial Design
HSMN NewsFeed - 22 May 2007
Advancis Pharmaceutical Announces FDA Acceptance of Amoxicillin PULSYS NDA
Advancis Pharmaceutical Announces FDA Acceptance of Amoxicillin PULSYS NDA
HSMN NewsFeed - 23 Mar 2007
Advancis Pharmaceutical Resubmits New Drug Application for Once-Daily Amoxicillin PULSYS
Advancis Pharmaceutical Resubmits New Drug Application for Once-Daily Amoxicillin PULSYS
HSMN NewsFeed - 28 Feb 2007
Advancis Pharmaceutical Reaches Agreement with FDA for Resubmission of Amoxicillin PULSYS NDA
Advancis Pharmaceutical Reaches Agreement with FDA for Resubmission of Amoxicillin PULSYS NDA
HSMN NewsFeed - 31 Jan 2007
Ranbaxy Gains FDA Approval to Market Amoxicillin and Clavulanate Potassium for Oral Suspension USP
Ranbaxy Gains FDA Approval to Market Amoxicillin and Clavulanate Potassium for Oral Suspension USP
HSMN NewsFeed - 14 Dec 2006
Ranbaxy Is Granted Final Approval to Manufacture and Market Cefprozil Anti- Infective Tablets
Ranbaxy Is Granted Final Approval to Manufacture and Market Cefprozil Anti- Infective Tablets
HSMN NewsFeed - 22 Nov 2006
OctoPlus Grants Green Cross Corporation Exclusive Korean License to OP-145 for Chronic Middle ear Infection
OctoPlus Grants Green Cross Corporation Exclusive Korean License to OP-145 for Chronic Middle ear Infection
HSMN NewsFeed - 22 Sep 2006
Merck and Nicaragua Unveil New Rotavirus Vaccine Demonstration Project at Clinton Global Initiative
Merck and Nicaragua Unveil New Rotavirus Vaccine Demonstration Project at Clinton Global Initiative
HSMN NewsFeed - 10 Aug 2006
Advancis Pharmaceutical Announces Positive Results for Amoxicillin PULSYS Phase III Trial
Advancis Pharmaceutical Announces Positive Results for Amoxicillin PULSYS Phase III Trial
HSMN NewsFeed - 1 Jun 2006
Advancis Pharmaceutical Completes Enrollment in Amoxicillin PULSYS Phase III Trial
Advancis Pharmaceutical Completes Enrollment in Amoxicillin PULSYS Phase III Trial
HSMN NewsFeed - 15 May 2006
Advancis Pharmaceutical Receives FDA Approval Letter for New Strengths of Keflex
Advancis Pharmaceutical Receives FDA Approval Letter for New Strengths of Keflex
HSMN NewsFeed - 28 Feb 2006
Advancis Pharmaceutical Strengthens Sales and Marketing Capability With Addition of Key Personnel
Advancis Pharmaceutical Strengthens Sales and Marketing Capability With Addition of Key Personnel
Additional items found! 41

Members Archive contains
41 additional stories matching:
otitis media
(Password required)
otitis media
(Password required)